Anthropometry and bioelectrical impedance analysis compared to dual-photon absorptiometry for the assessment of body composition of HIV-seropositive patients;Antropometría y análisis de impedancia bioeléctrica comparado con absorciometría fotónica dual para la evaluación de la composición corporal en pacientes infectados por VIH

Revista Chilena de Nutricion

Volumn 38, Issue 4, 2011, Pages 404-413

  Beraldo, Rebeca Antunes ^a   Vassimon, Helena Siqueira ^a   Alceu, Afonso Jordãeo J ^a   de Albuquerque, Francisco José ^a   Machado, Alcyone Marchioli ^a   de Freitas, Maria Cristina Foss ^a   Navarro, Anderson Marliere ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anthropometry; HIV; Lipodystrophy; Segmental bioelectrical impedance

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84858117248     PISSN: 07177518     EISSN: None     Source Type: Journal    
DOI: 10.4067/S0717-75182011000400002     Document Type: Article

References (44)

1. Fauci AS. HIV and AIDS: 20 years of science. Nat Med, 2003, 9(7): 839-43.
2. Potthoff A, Brocmeyer NH, Gelbrich G, Neuhaus K, Stefa E, Reinsch N, et al. Lipodystrophy-a sing for metabolic syndrome in patients of the HIV-HEART study. J Dtsch Dermatol Ges 2010, 8:92-8.
3. Wand H, Calmy A, Carey DL, Samaras K, Carr A, Law MG et al. Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS 2001, 21(18):2445-53.
4. Torriani M, Thomas BJ, Barlow RB, Librizzi J, Dolan S, Grinspoon S. Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution. J Applied Physiology (Bethesda), 2006;100 (2) 609-14.
5. Batterham MBD, Garsia R. Nutritional management of HIV/AIDS in the era of highly active antiretroviral therapy: a review. Australian J Nutr Diet 2001; 58(4): p. 211-23.
6. Bedimo RJ. Body-Fat Abnormalities in Patients With HIV: Progress and Challenges. J Int Assoc Physicians AIDS Care (Chic Ill) 2008; 7:292-305.
7. Walton C, Lees B, Crook D, Godsland IF, Stevenson JC. Relationships between insulin metabolism, serum lipid profile, body fat distribution and blood pressure in healthy men. Atherosclerosis 1995;118(1): 35-43.
8. Von Eyben FE, Mouritsen E, Holm J, Montvilas P, Dimcevski G. Intraabdominal obesity and metabolic risk factors: a study of young adults. Int J Obes 2003, 27(8): 941-9.
9. Moore FD, Olesen KH, McMurrey JD, Parker HV, Ball MC, Boyden CM: The body cell mass and its supporting environment, in Body Composition Analysis in Health and Disease, Philadelphia, W.B. Saunders, 1963, p 1484-508.
10. Kotler DP, Tierney AR, Wang J, Pierson RN. Mag- nitude of bodycell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989; 50: 444-7.
11. Oppliger RA, Nielsen DH, Shetler AC, Crowley ET, Albright JP. Body composition of collegiate foot-ball players: bioelectrical impedance and skinfolds compared to hydrostatic weighing. J Orthop Sports Phys Ther 1992; 15(4):187-92.
12. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gomez JM, Heitmann BL, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, Schols AM, Pichard C. Bioelectrical impedance analysis-part I: review of principles and methods. Clin Nutr(Kidlington) 2004; 23 (5):1226-43.
13. Kushner RF. Bioelectrical impedance analysis: a review of principles and applications. J Am Coil Nutr, 1992, 1 1:199-209.
14. Kotler DP, Burastero S, Wang J, Pierson Jr RN. Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effects of race, sex, and disease. Am J Clin Nutr (Bethesda), 1996; 64, (3) 489S-97S.
15. Baumgartner RN, Chumlea WC, Roche AF. Estimation of body composition from bioelectric impedance of body segments. Am J Clin Nutr 1989, 50: 221-6.
16. Nicholas IP, Ma MRCP, Marinos Elia MD, Graham J, Leigh CW, George E. Griffin, Phd, Frcp. Bioelectrical impedance analysis in human immunodeficiency virus-infected patients: comparison of single frequency with multifrequency, spectroscopy, and other novel approaches. Nutrition 1998; 14: 658-66.
17. Sutinen J, Yki-Jarvinen H. Increased resting energy expenditure, fat oxidation, and food intake in patients with highly active antiretroviral therapy-associated lipodystrophy. American journal of physiology. Endocrinol Metab (Bethesda); 2007; 292, (3): 687-92.
18. Bonnet E, Delpierre C, Sommet A. Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men. J Clin Densitom 2005; 8:287-92.
19. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Abridged edition, 1991, p. 90.
20. Frisancho AR. Triceps skinfold and upper arm muscle size norms for assessmemt of nutritional status. Am J Clin Nutr 1974, 27: 1052-58.
21. Frisancho AR. Anthropometric standards for the assessment of growth and nutritional status. University of Michigan, 1990, p.189.
22. Chumlea WC, Baumgartner RN, Roche AF. Specific resistivity to estimate fat free mass from segmental body measures of bioelectric impedance. Am J Clin Nutr 1988; 48: 7-15.
23. Baumgartner RN, Chumlea WC, Roche AF. Estimation of body composition from bioelectric impedance of body segments. Am J Clin Nutr 1989; 50: 221-6.
24. St Laurent RT. Evaluating Agreement with a Gold Standard in Method Comparison Studies. Biometrics 1998; 54: 537-45.
25. ® User's Guide, Version 9, Cary, NC, USA: SAS Institute Inc., 2002-2003.
26. Boskurt B. Cardiovascular toxicity with highly ac- tive antiretroviral therapy: review of clinical study. Cardiovasc Toxicol 2004;4(3):243-60.
27. Hodgson TA. HIV-associated oral lesions: prevalence in Zambia. Oral Diseases 1997, 3: 46-50.
28. Hansen BR, Petersen J, Haugaard SB, Madsbad S, Obel N, Suzuki Y et al. The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy. HIV Méd 2009, 10(6):378-87.
29. Fichtenbaum CJ. Metabolic abnormalities associated with HIV infection and antiretroviral therapy. Curr Infect Dis Rep. 2009; 11(1):84-92.
30. Heath K, Chan KJ, Singer J, et al. Incidence of morphological and lipid abnormalities: Gender and treatment differentials after initiation of first antiretroviral therapy. Intern J Epidemiol 2002, 31:1016-20.
31. Martinez E, Mocroft A, García-Viejo MA, Pérez- Cuevas JB, Blanco JL, Mallolas J. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet 2001; 357(9256): 592-8.
32. Pereira AR. Avaliação antropométrica do estado nutricional. In: Sichieri R. Epidemiologia da obesidade. Rio de Janeiro; EdUERJ, 1998, p. 43-63.
33. World Health Organization (WHO). Diet, nutrition and the prevention of chronic diseases. Report of a joint WHO/FAO expert consultation Geneva; WHO-Technical Report Series, 2003, 916.
34. Mcdermott AY, Shevitz A, Knox T, Roubenoff R, Kehayias J, Gorbach S. Effect of high active antiretroviral therapy on fat, lean, and bone mass in HIVseropositive men and women. Am J Clin Nutr 2001; 74(5): 679-86.
35. Visnegarwala F, Raghavan SS, Mullin CM, Bartsch G, Wang J, Kotler D, Gibert CL, Shlay J, Grunfeld C, Carr A, El-Sadr W. Sex differences in the association of HIV disease characteristics and body composition in antiretroviral-naive persons. Am J Clin Nutr, Bethesda, 2005; 82, (4) 850-6.
36. Vassimon HS, Deminice R, Machado AA, Monteiro JP, Jordao Jr AA. The Association of Lipo-dystrophy and Oxidative Stress Biomarkers in HIV-Infected Men. Current HIV Research (Print), 2010; 8: 364-9.
37. Aghdassi E, Arendt B, Salit IE, Allard JP. Estimation of body fat mass using dual-energy x-ray absorptiometry, bioelectric impedance analysis, and anthropometry in HIV-positive male subjects receiving highly active antiretroviral therapy. JPEN J Parenter Enteral Nutr 2007; 31 (2): 135-41.
38. Valerio CM, Godoy-Matos A, Moreira RO, Carraro L, Guedes EP, Moises RS, Mory PB, De Souza LL, Russo LA, Melazzi A C. Dual-energy X-ray absorptiometry study of body composition in patients with lipodystrophy. Diabetes Care 2007; 30(7): 1857-9.
39. Schwenk A. Methods of assessing body shape and composition in HIV associated lipodystrophy. Curr Opin Infect Dis 2002;15(1): 9-16.
40. Jacobson DL, Knox T, Spiegelman D, Skinner S, Gorbach S, Wanke C. Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, Chicago, 2005; 40:1837-45.
41. Busnello FM. Aspectos nutricionais no processo do envelhecimento. 1 ed. São Paulo (SP): Atheneu, 2007.
42. Guedes DP. Composição corporal: princípios, técnicas e aplicações. 2a ed. Londrina: APEF; 1994
43. Heyward VH, Stolarczk IM. Avaliação da composição corporal aplicada. São Paulo: Manole; 2000.
44. Wanke C, Polsky B, Kotler D. Guidelines for using body composition measurement in patients with human immunodeficiency virus infection. AIDS Patient Care STDS, Larchmont, 2002, v. 16, n. 8, p. 375-88.